Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 62

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression

Lee, Yena, Subramaniapillai, Mehala, Brietzke, Elisa, Mansur, Rodrigo B., Ho, Roger C., Yim, Samantha J., McIntyre, Roger S. · 2018 · Therapeutic Advances in Psychopharmacology

Abstract

The etiology of mood disorders is mechanistically heterogeneous, underscoring the need for a dimensional approach to identify and develop targeted treatments in psychiatry. Accumulating evidence implicates inflammation as an important contributor to the pathophysiology of depression and presents the immune system as a viable therapeutic target that may be more proximate to the pathogenic nexus of brain-based disorders in specific subpopulations. Anhedonia is a transdiagnostic (e.g. Parkinson’s disease, diabetes mellitus, rheumatic diseases), yet specific, and clinically relevant symptom dimension subserved by well-characterized neurobiological and neurophysiological substrates of the positive valence systems (PVS). Brain circuits, nodes, and networks, as well as cellular and molecular pathways (e.g. dopaminergic transmission; excitotoxicity; synaptic plasticity), subserving anhedonia are preferentially affected by inflammatory processes. To our knowledge, no published randomized, controlled clinical trial in populations with mood disorders has, to date, primarily sought to determine the effects of an anti-inflammatory agent on PVS functions or pathophysiology. Three ongoing clinical trials aim to investigate the effects of anti-TNF-alpha biologic infliximab on measures of anhedonia [ClinicalTrials.gov identifier: NCT02363738], motivational behavior and circuitry [ClinicalTrials.gov identifier: NCT03006393], and glutamatergic changes in the basal ganglia [ClinicalTrials.gov identifier: NCT03004443] in clinical populations with unipolar or bipolar depression. Positive results would further instantiate the relevance of inflammatory processes and the immune system in the pathophysiology of mood disorders and provide the impetus to develop scalable treatments targeting inflammation and the immune system to mitigate transdiagnostic, dimensional disturbances in brain-based disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/2045125318791944

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Research works printed but not linked: 58

  1. 10.1176/appi.ajp.157.6.867 · DOI · Paper page
  2. 10.1016/j.jpsychores.2014.07.020 · DOI
  3. 10.1016/j.neuroimage.2012.06.055 · DOI · Paper page
  4. 10.1016/0006-8993(92)91588-6 · DOI · Paper page
  5. 10.1006/brbi.2000.0613 · DOI · Paper page
  6. 10.1155/2016/9085273 · DOI
  7. 10.1176/appi.psy.44.2.104 · DOI · Paper page
  8. 10.4088/JCP.v66n0814 · DOI
  9. 10.1176/jnp.16.2.185 · DOI
  10. 10.1016/S0165-0327(02)00264-1 · DOI · Paper page
  11. 10.1016/j.bbi.2015.12.005 · DOI
  12. 10.1007/s10067-010-1651-8 · DOI
  13. 10.1111/j.1756-185X.2010.01591.x · DOI
  14. 10.1016/j.neubiorev.2014.12.017 · DOI · Paper page
  15. 10.1097/JCP.0b013e3181bef8a6 · DOI
  16. 10.1111/bdi.12166 · DOI
  17. 10.4088/JCP.08r04505 · DOI · Paper page
  18. Marrie RA, 2017, Epidemiol Psychiatr Sci, 1
  19. 10.1017/S0033291708003188 · DOI · Paper page
  20. Ho RC, 2010, Ann Acad Med Singapore, 39, 191, 10.47102/annals-acadmedsg.V39N3p191 · DOI
  21. 10.1038/nm.3893 · DOI · Paper page
  22. 10.1016/j.biopsych.2013.01.007 · DOI · Paper page
  23. 10.1016/j.biopsych.2009.09.033 · DOI · Paper page
  24. 10.1002/brb3.200 · DOI
  25. 10.1192/apt.bp.113.011619 · DOI
  26. 10.1038/srep35239 · DOI
  27. 10.1016/j.jpsychires.2015.12.003 · DOI
  28. 10.1523/JNEUROSCI.1671-13.2013 · DOI · Paper page
  29. 10.1001/jamapsychiatry.2014.2427 · DOI · Paper page
  30. 10.1016/j.biopsych.2009.11.005 · DOI · Paper page
  31. 10.1016/j.bbi.2011.10.010 · DOI · Paper page
  32. 10.3899/jrheum.150884 · DOI
  33. 10.1176/appi.ajp.2010.09091379 · DOI · Paper page
  34. 10.1176/appi.books.9780890425596 · DOI · Paper page
  35. 10.1016/j.schres.2014.10.028 · DOI
  36. 10.1097/NMD.0b013e3182349ce6 · DOI
  37. Rømer Thomsen K, 2015, Front Behav Neurosci, 9, 49
  38. 10.1097/YCO.0000000000000122 · DOI · Paper page
  39. 10.1016/j.psyneuen.2016.04.002 · DOI
  40. 10.1192/bjp.bp.114.154781 · DOI
  41. 10.1001/archgenpsychiatry.2010.36 · DOI
  42. 10.1016/j.clineuro.2013.10.013 · DOI
  43. 10.1016/j.jns.2006.05.024 · DOI
  44. 10.1176/appi.neuropsych.11110332 · DOI
  45. 10.1017/S0033291707001730 · DOI · Paper page
  46. Haber SN., 2012, Neurobiology of sensation and reward
  47. 10.1002/hbm.21268 · DOI · Paper page
  48. 10.1016/j.jad.2016.09.056 · DOI · Paper page
  49. 10.1007/s00702-014-1187-1 · DOI
  50. 10.1038/npp.2016.143 · DOI · Paper page
  51. 10.1038/npp.2016.191 · DOI
  52. 10.1016/j.biopsych.2009.03.015 · DOI · Paper page
  53. 10.1176/appi.ajp.2016.16070774 · DOI · Paper page
  54. 10.4088/JCP.16m11310 · DOI
  55. 10.4088/JCP.14m09587 · DOI
  56. 10.1038/mp.2015.22 · DOI · Paper page
  57. Schmidt FM, 2014, Psychiatr Danub, 26, 288
  58. 10.1016/j.pharmthera.2007.10.001 · DOI · Paper page

Cited by

See all 62

Metadata

Authors
Lee, Y., Subramaniapillai, M., Brietzke, E., Mansur, R. B., Ho, R. C., Yim, S. J., & McIntyre, R. S.
Affiliations
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada Institute of Medical Science, University of Toronto, Toronto, ON, Canada
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada
  • Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada Department of Psychiatry, University of Toronto, Toronto, ON, Canada
  • Department of Psychological Medicine, National University of Singapore, Singapore
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada Institute of Medical Science, University of Toronto, Toronto, ON, Canada Department of Psychiatry, University of Toronto, Toronto, ON, Canada Department of Pharmacology, University of Toronto, Toronto, ON, Canada
Venue
Therapeutic Advances in Psychopharmacology
Published
2018-11-19
Volume
8
Issue
12
Pages
337-348
ISSN
  • 2045-1253
  • 2045-1261
Cited by
62
References
51
Language
en
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression. https://app.cochat.ai/papers/10.1177/2045125318791944
The paper
Lee, Y., Subramaniapillai, M., Brietzke, E., Mansur, R. B., Ho, R. C., Yim, S. J., & McIntyre, R. S. (2018). Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125318791944

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.